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Granulocytes and monocytes are known to phagocytose and kill numerous varieties 
of bacteria and parasites. This function is intimately associated with an early event 
called the  "respiratory burst," which  includes  the generation  of 02-  and  H202  (1). 
These  and  other  highly  reactive  molecular  species  can  easily  be  detected  in  the 
presence  of luminol  or  other  readily  oxidized  substrates  by  the  emission  of light 
(chemiluminescence), a phenomenon first described by Allen et al. (2) in reference to 
phagocytosing  neutrophils.  The exact  mechanism of chemiluminescence  is not  yet 
understood  (3) but appears related, in part, to species of singlet oxygen and electron- 
ically excited carbonyl groups that relax with ensuing light emission (2). 
The respiratory burst is essential for chemiluminescence because it does not occur 
in resting cells, in stimulated cells from patients with chronic granulomatous disease, 
or in normal stimulated cells kept under anaerobic conditions  (2, 4, 5).  Chemilumi- 
nescence  is  also  impaired  in  myetoperoxidase-  (MPO) 1 deficient  leukocytes  or  by 
treatment  of cells  with  heme  enzyme inhibitors  such  as  sodium  azide  (2,  4-6).  In 
addition, phagocytosis-associated chemiluminescence in normal cells is attenuated by 
both superoxide dismutase  (SOD)  and catalase (5-7)  and is correlated in time with 
the formation of 02- and H202  (8).  These and other data indicate that chemilumi- 
nescence  is  dependent  on  the  availability of 02,  the  activity of the  initial  oxidase 
responsible  for 02-  formation,  the  presence  of 02-  and  H202,  and  the  activity of 
MPO. 
Microbes are thought  to be killed directly by cell-derived H202 and possibly 02- 
and certain  free radicals.  Tumor cells, on the other hand,  are destroyed in  part by 
natural  killer  (NK)  cells  (10)  in a  process that  does not involve phagocytosis, much 
like  nonphagocytic  killing  of tumor cells  by  maerophages.  It  has  previously been 
shown that  murine macrophages use H202 in their cytolytic mechanism (11),  as do 
human  neutrophils  (12),  but  very little is known about the cytolytic mechanism  in 
NK cells.  In  this  paper,  we  show  that  the  NK-target cell  interaction  results  in  an 
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immediate burst of chemiluminescence. The degree of chemiluminescence is directly 
correlated with the sensitivity of the target cells to NK-mediated binding and cytolysis. 
In  addition, the  generation of chemiluminescence is dependent  upon  the degree of 
activation because interferon-boosted NK cells show increased chemiluminescence. It 
is postulated that those cellular reactions that generate chemiluminescence could be 
important in the cytolytic pathway of human  NK cells. 
Materials  and  Methods 
Cell Lines.  All cell lines were maintained by continuous in vitro culture and were free of 
mycoplasma at the time of testing. K562 is a human erythroleukemic cell line derived from the 
pleural effusion of a patient with chronic myelogenous leukemia in terminal blast crisis. K562- 
induced clones A4, G8, and B were derived from the K562 cell line grown in  1 mM sodium 
butyrate or 0.1  mM  haemin  and  maintained  in  culture  for  several months  after cloning. 
Erythroid  induction  was  monitored  by  gross cytoplasmic changes  (increased granularity), 
benzidine (Lephene's) staining, increases in quinhydrone production and hemoglobin synthesis, 
and increased amounts of glycophorin (13).  P815 is a  mastocytoma induced in DBA/2 mice 
with  methylcholanthrene.  YAC is a  Moloney leukemia virus-induced T  cell lymphoma of 
A/Sn mice origin. L5178Y is a lymphoma induced in DBA/2 mice with methylcholanthrene. 
Chang is a human hepatocarcinoma. Human embryonic fibroblasts (HEF) were in passage 10 
of primary cell culture. MeWo is a human melanoma. 
Effector Cells.  Heparinized venous blood was treated for 30 min at 37°C with carbonyl iron 
(type E; A. D. McKay, Darien, CT;  100 mg per 10 ml blood). The blood was then passed over 
a magnet followed by centrifugation (1,000 g, 10 min) on Ficoll-Hypaque (specific gravity 1.077 
g/era ). The mononuclear cell band was collected and incubated for  1 h  at 37°C on plastic 
culture dishes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) precoated with 
autologous plasma. The nonadherent  lymphocytes contained <1%  monocytes as assessed by 
phagocytosis of antibody-coated ox  erythrocytes  or  latex  particles, by  immunofluorescent 
staining with Mo2, a monoclonal antibody specific for the entire human monocyte population 
(14), or by cytoehemical stains for esterase and peroxidase. In control studies, carbonyl iron did 
not affect monocyte detection by any of these methods. Contamination with granulocytes was 
*z0.1% as judged in Giemsa cytocentrifuge preparations and immunofluoreseent staining with 
a monoclonal antibody specific for human granulocytes. 
Monocytes.  Human  peripheral blood mononuclear cells (5 ml at 3-4 ×  10  s cells/ml) were 
incubated for 1 h at 37°C on 60-mm plastic culture dishes (Falcon Labware, Div. of Becton, 
Dickinson  &  Co.)that  had  been  precoated  for  15  min  at  37°C  with  autologous plasma. 
Nonadherent  cells were collected, and  the dishes were  then  thoroughly washed  with warm 
medium.  Strongly adherent cells were recovered by trypsinization and incubated for 6 h  at 
20°C in culture medium to allow "recovery." Adherent cells consisted of >95% monocytes as 
assessed by nonspecific acid esterase and  peroxidase staining and  immunofluorescence with 
monoclonal Mo2 antibody. 
Granuloqytes.  Human  granuiocytes  were  collected  by  unit  gravity sedimentation  of the 
erythrocyte-granulocyte pellet obtained after Ficoll-Hypaque removal of mononuclear cells. 
Percoll Fractionation.  Discontinuous Percoll (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway, N  J) density gradients were made essentially as described by Timonen and 
Saksela (15).  Briefly, the top layer consisted of 40%  Percoll (vol/vol) diluted in medium and 
adjusted to 285  mosmol/kg H20 with  10-fold-concentrated phosphate-buffered saline (PBS) 
using an Osmette osmometer (Fisher Scientific Co., Pittsburgh, PA). The refractive index of 
this top fraction was adjusted to 1.3432, and subsequent fractions were established by increasing 
the density of the Percoll by 2.5% increments. The gradient was loaded with ~10  s monocyte- 
depleted lymphocytes and centrifuged at 550 g  for 30 min  at 20°C.  The lymphocyte bands 
were collected and washed twice in medium, whereas the pellet, consisting mainly of erythro- 
eytes, was discarded. Lymphocyte fractions along with unfractionated cells were tested in a 
2-h 51Cr release assay against K562 to determine which fraction contained peak NK activity. 
Immunofluorescence.  Lymphocytes (5 ×  105 in 0.1 ml RPMI containing 1 mM NaN3 and 10% 
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HNK-1 antibody (IgM-kappa) (16), washed twice, and incubated for a further 1 h at 0°C with 
a  1/I0 dilution of rhodamine-labeled [F(ab')2 fragment] goat anti-mouse IgM (N. L. Cappel 
Laboratories Inc., Cochranville, PA),  as  described by Abo and Balch  (16). The cells  were 
washed twice and prepared as wet mounts. 500 cells were counted using a fluorescent microscope 
(E.  Leitz, Federal Republic of Germany). In some experiments, the cells were stained with 
monoclonals OKT3 (Ortho Pharmaceutical, Raritan, N  J)  (1/50) or Mo2 (1/100)  (generously 
provided by Dr. R. Todd and Dr. S. Schlossman, Boston, MA) followed  by a  1/10 dilution of 
fluoreseein isothiocyanate-labeled (F(ab')2 fragment) sheep anti-mouse IgG (H  and L chain 
specific;  N. L. Cappel Laboratories Inc.). 
Conjugate-forming Cell Assay.  Monocyte-depleted lymphocytes from the highly NK-enriched 
fraction of Percoll gradients were mixed with a fivefold excess of tumor cells, centrifuged at 150 
g for 5 min at 20°C, and then stored on ice. Pellets were gently resuspended, and the number 
of lymphocytes binding  to tumor cells was determined in duplicate by counting  200 lymphocytes 
in a hemacytometer. 
Cytolytic Assays.  Target cells labeled with 5XCr (sodium chromate) were mixed with varying 
numbers of effeetor cells in 150/L1 in V-bottomed microplates (Linbro Chemical Co., Hamden, 
CO)  in triplicate samples. The microplates were  centrifuged at  150 g  for  5  min and then 
incubated in a 37°C humidified 5% CO2 incubator for 4 or 18 h. After incubation, the plates 
were again centrifuged for 10 min, and 100-#1 samples were removed for counting in a gamma 
counter (Beckman Instruments,  Inc., Fullerton,  CA). The percentage cell-mediated lysis (percent 
CML) was calculated as follows:  percent CML =  100 ×  ([cpm test -  cpm medium])/([cpm 
max  -  cpm  medium]). The  epm  (max)  was  determined by counting a  100-/~1 aliquot  of 
resuspended target  cells.  Counts per minute (medium) was determined in wells  containing 
targets only with no effectors added. 
Lytic Units.  Lytic units (LU) were calculated from effector  titration curves, and 1 LU was 
defined as the number of effector  cells required to achieve 20% lysis. LU/107 is the number of 
LU in 10 million effeetor cells. 
Interferon Treatment.  For cytolytic assays,  5  million monocyte-depleted lymphocytes were 
incubated (106 cells/ml) for  1 h at 37°C with 200 U/ml of purified fibroblast interferon (10  a 
U/mg protein; generously provided by C. Tan, University of Calgary) or with medium as 
control and washed twice before use.  For chemiluminescence assays,  5  ×  105 NK-enriched, 
Percoll fraction cells were incubated for 1 h at 25°C with 200 U/ml of interferon, washed, and 
then used. 
Glutaraldehyde Treatment.  Glutaraldehyde (Sigma Co., St. Louis, MO) was made up to 0.20 
and 0.25% from two different batches. 30 ×  107 K562 target cells or 106 NK-enriched Percolt 
fraction lymphocytes were added to 10 ml of a glutaraidehyde solution, incubated at 37°C for 
either 1 or 2 h, washed three times with PBS, and stored at 4°C in PBS until used. 
Chemiluminescence.  One-half  or 1 million lymphocytes from the NK-enriched Percoll fraction 
were dark-adapted for 30 min at  20°C in 0.8 ml of 10% luminol (3-aminophthalhydrazide; 
Eastman Kodak Co.,  Rochester,  NY)-saturated FCS in plastic scintillation vials.  10 million 
target  cells  or  medium  alone was  added  in  0.1-ml  volumes  and  mixed  under  red  light 
illumination. Chemiluminescence was measured at ambient temperature (20°C)  in an LKB 
liquid scintillation counter (LKB Instruments, Inc., Rockville, MD) in the out-of-coincidence 
mode (17). Counts per minute were recorded at 5-s intervals. Luminol alone gave a background 
of-35 ×  10  a epm, and Percoll-fractionated lymphocytes with luminol had a background of 50 
×  10  a cpm.  10  7 target ceils tested with luminol gave no chemiluminescence above that of the 
luminol alone. 
Plasma Membrane Vesicles.  108 tumor cells were disrupted in a nitrogen bomb, and plasma 
membrane vesicles were isolated on sucrose density gradients as described previously (18). 
Statistical Analysis.  The differences between experimental groups were determined using a 
two-tailed Student's t  test.  The significance of linear regressions  was  determined using the 
Fisher exact test. 
Results 
Chemiluminescence  Follows NK  Target-Effector Interaction.  NK cells were enriched by 
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addition  of K562  tumor cells led  to  a  rapid  chemiluminescence  response that  was 
directly proportional to the concentration of effector cells or targets, as shown in Fig. 
1. In the presence of a fixed number of l0  T target cells, 106 NK-enriched lymphocytes 
generated a peak chemiluminescent response of 2 X  106 counts over the  10-min assay 
period  (Fig.  1,  left  panel).  The  reason  for  the  decline  in  the  chemiluminescence 
response  when  the  effectors  were  increased  to  2  ×  106  is  not  known  but  could 
conceivably arise because of the release of SOD or scavengers from cells killed at this 
higher effector/target ratio. When the effector cells were held constant at 0.5  ×  106, 
a  near maximum chemiluminescence  response was  observed upon  addition  of  107 
intact K562 cells (Fig.  1, right panel). In subsequent assays, therefore, we used 0.5 × 
106 Percoll fractionated effector cells and  l0  T intact target cells. 
Plasma membrane vesicles of K562 were less able to induce chemiluminescence at 
high concentrations compared with intact K562 cells, whereas low numbers of vesicles 
(0.01  ×  106 cell equivalents, 0.028 #g protein) generated markedly more chemilumi- 
nescence than  intact  K562 cells.  Because each K562 cell yields many plasma mem- 
brane vesicles, one would expect intact cells to be more limiting than vesicles, as we 
observed. These results imply that a  given number of hits is necessary to trigger the 
NK cells regardless of particle size. Vesicles prepared from an NK-insensitive target, 
P815,  failed to induce any detectable chemiluminescence response. 
In these experiments, we used  mixtures of targets and effectors without  knowing 
exactly  which  cell  type  was  generating  the  oxygen  radicals.  Therefore,  we  used 
glutaraldehyde  fixation  to  inactivate  one  of the  two  partners.  The  NK-enriched 
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Fio.  1.  Effector/target  titrations in the chemiluminescence assay. Monocyte-depleted peripheral 
blood  lymphocytes were separated on Percoll  density gradients, and the fraction  highest in NK- 
mediated cytotoxicity was selected for further study. Left panel: varying numbers of these lympho- 
cytes were mixed with 107 K562 cells at a time 0 in the presence ofluminol, and cpm were recorded 
every 5 s on an LKB liquid scintillation counter in the out-of-coincidence mode (0).  Right panel: 
varying numbers of intact  K562  cells  were  mixed with  5  ×  105  NK-enriched  Percoll  fraction 
lymphocytes (A). Cell-free plasma membrane vesicles were prepared  from K562 (A) and P815 (O) 
cells and mixed with  5  ×  105 NK-enriched Percoll  fraction  lymphocytes.  107 cell  equivalents of 
plasma membrane vesicles contained 28 #g of protein. Target cells or vesicles alone did not generate 
chemiluminescence. Values represent mean total cpm above background +  SE over a  10-min period 
in triplicate samples. This experiment was repeated three times with similar results. 496  CHEMILUMINESCENCE RESPONSE OF HUMAN NATURAL KILLER CELLS 
Percoll  fraction  was  fixed  for  1 h  at  37°C  in  0.20%  glutaraldehyde  (lot  2)  and  then 
washed  extensively  in  PBS.  When  107  K562  cells  were  added,  no  response  above 
background  was  detected  in  the chemiluminescence  assay,  as  shown  in  Fig.  2.  51  + 
2% of the fixed NK cells formed conjugates with K562 in a  single-cell assay, compared 
with 49  +  4%  of unfixed  NK  cells. Therefore,  the glutaraldehyde  treatment  did  not 
affect  the  ability  of NK  cells  to  bind  to  the  target  cells.  The  same  glutaraldehyde 
treatment  of monocytes completely abolished  the chemiluminescence response to the 
chemotactic  peptide  N-formyl-L-methionyl-L-leucyl-L-phenylalanine  (data  not 
shown).  Therefore,  glutaraldehyde  treatment  seems  to  abolish  the ability of cells to 
generate chemiluminescence in general. 
Glutaraldehyde  fixation  of K562  target  cells under  mild conditions  preserved  the 
target  structure  because  these  cells were almost  as  efficient as  unfixed  K562  cells in 
competing  with  51Cr-labeled  targets  in  a  cytolytic  assay,  as  shown  in  Table  I. 
Conjugate  formation  with  Percoll  fraction  2  lymphocytes  was  also  within  normal 
range, and the fixed target cells induced almost as much chemiluminescence  (97%)  as 
unfixed  K562  cells.  These  results  show  that  it  is the  NK-enriched  lymphocytes  that 
respond  to  K562  cells by generating  chemiluminescence,  whereas  the target  cells do 
not  respond  to the effectors.  It is also noteworthy  that  K562  cells subjected  to harsh 
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FIo.  2.  Induction of chemiluminescence with glutaraldehyde-fixed target cells. Monocyte-depleted 
peripheral blood lympocytes were separated on Percoll density gradients,  and the fraction highest 
in NK-mediated cytotoxicity was selected  for further study.  5 ×  10  s NK-enriched Percoll  fraction 
lymphocytes were mixed with  10  r untreated K562 cells (O) or  10  7 K562 cells fixed using glutaral- 
dehyde treatment protocols a (X), b (A), or c (0) at time 0 in the presence of luminol, and cpm were 
recorded every 5 s on an LKB liquid scintillation counter in the out-of-coincldence mode. 10  7 K562 
cells were treated with (a) 0.20% glutaraldehyde (lot 2) for  1 h at 37°C; (b) glutaraldehyde (lot 2) 
at a concentration of 0.25% for 1 h at 37°C; or (c) glutaraldehyde (lot 1) at a concentration of 0.25% 
for 2 h at 37°C. NK-enriched Percoll fraction lymphocytes were treated with glutaraldehyde 0.20% 
(lot 2) for 1 h at 37°C and washed three times with PBS. 5 X  105 of these fixed lymphocytes were 
mixed with  107 K562 cells, and chemiluminescence was measured as above (1"]). Values represent 
cpm above background. The area under each curve varied <3% in repeat samples. This experiment 
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TABLE  I 
Target Cell Competition and Chemiluminescence Induced with Glutaraldehyde-fixed K562 Target Cells 
Chemilumines- 
Competitor/  Cells required  Percent  cencell 
Treatment*  target ratio for  for 20% inhibi- 
20% inhibition:[:  tion X 10"4:~  conjugates§ 
Percent control 
Untreated K562  3/1  6 4- 2  58 ±  4  100 4- 2 
Glutaraldehyde-treated  7.5/1  15 +  3  53 +  3  97 ±  3 
K562  (a) 
Glutaraldehyde-treated  42/1  84 -4- 5  22 ±  2  74 4- 1 
K562  (b) 
Glutaraldehyde-treated  143/1  286 4- 10  9 ±  3  20 ±  3 
K562 (c) 
* Treatment protocol: (a)  107 K562 cells were treated with 0.20% glutaraldehyde lot 2 for 1 h at 37°C. (b) 
107 K562  cells were treated with 0.25% glutaraldehyde lot 2 for  1 h at 37°C.  (c)  l0  T K562  cells were 
treated with 0.25% glutaraldehyde lot 1 for 2 h at 37°C. 
:~ Unfixed or glutaraldehyde-fixed K562  cells were added at varying ratios (from 0.3/1  to 20/1) to a 4-h 
SlCr release assay of NK-enriched Percoll fraction lymphocytes and K562 target cells (ratio, 50/1). Values 
are expressed  as the competitor/target ratio or mean competitor cell number ±  SE required to inhibit 
lysis by 20% in triplicate samples.  The actual percent lysis was 70%. 
§ Percoll fraction-2  cells were mixed with K562 cells at a  1:5 ratio, and the percent lymphocytes bound to 
K562  (conjugates)  was  determined  after  counting  200  lymphocytes.  Values  represent  the  mean  of 
triplicate samples  ±  SE. 
U  Chemiluminescence of NK-enriched Percoll  fraction lymphocytes was  measured over a  10-rain period, 
and the area under the curve was integrated. Values are expressed as the mean percent chemiluminescence 
induced by glutaraldehyde-fixed K562 cells compared with the unfixed control ± SE in triplicate samples. 
The control value was 4 ×  10  s total counts over 10 min. 
fixation conditions were less able to bind to the NK  cells or compete in a  cold target 
competition  assay and  were also less able to induce chemiluminescence.  As shown in 
Table I, there was a  direct correlation between the preservation of the target structure, 
as measured  in competition  assays  or conjugate formation,  and  the ability to induce 
chemiluminescence.  We then  asked whether  this relationship would hold in a  survey 
of different tumor  cell lines of varying NK  susceptibility. 
The Degree of Chemiluminescence Is Correlated with the NK Sensitivity of the Tumor Cell and 
the State of NK Activation.  We  chose a  panel  of nine  target  cell types  that  varied in 
their  sensitivity  to  NK-mediated  killing  and  macrophage  killing  for  further  study. 
The  most  highly  NK-enriched  Percoll  fraction  was  tested  in  a  standard  conjugate- 
forming  assay  with  each  of these  targets.  As  shown  in  Table  II,  there  was  a  direct 
relationship  between  conjugate  formation  and  sensitivity  to  NK-mediated  cytolysis. 
A  4-h  chromium  release  assay  was  used  to  evaluate  sensitivity  to  NK-mediated 
cytolysis  using  Ficoll-separated,  iron-treated,  and  plastie-nonadherent  peripheral 
blood lymphocytes as effectors. In the case of relatively insensitive targets, we used an 
18-h  cytolytic  assay.  The  data  were  calculated  as  LU/107  effectors  and  then  stan- 
dardized  to  the  K562  target  that  was  always  run  in  parallel.  As shown  in  Table  II 
and  Fig.  3,  K562  clones  A4,  B,  and  G8  each  had  a  marked  decrease  in  ability  to 
trigger chemiluminescence  (30-48%  of control), which correlated with a  reduction  in 
susceptibility to NK-mediated  cytolysis  (21-33%  of control)  and conjugate formation 
(22% of control) compared  with the K562 parent. These clones are selectively resistant 
to  NK  cells and  were derived from  K562  cells induced  to differentiate  by growth  in 
sodium butyrate  (13). 
L5178Y,  P815,  and  YAC were all relatively insensitive to human  NK  killing, even 498  CHEMILUMINESCENCE  RESPONSE OF HUMAN  NATURAL KILLER CELLS 
TABLE  II 
Chemiluminescence Induced by Target Cells of Varying NK Sensitivity 
Monocyte  Chemilumines-  NK cytolysis§  cytolysisl I 
cence*  Percent 
Target cell  conjugates:[:  Percent control  Percent control 
Percent control  LU  LU 
K562-uninduced parental  100 +  2  40 +  3  100 +  5  0.72 ±  0.1 
K562-induced clone A4  30 ±  4  8 ±  2  21 +  3  0.76 ±  0.2 
K562-1nduced clone B  48 ±  1  9 ±  1  33 ±  2  0.7l +  0.1 
K562-induced clone G8  48 ±  3  8 ±  2  33 ±  3  0.70 ±  0.1 
L5178Y  15 ±  1  2 ±  I  I ±  1  100 ±  4 
P815  20 ±  2  0 ±  0  5 ±  2  0.36 ±  0.1 
YAC  20±3  3±  1  4±  1  6.9±  1 
HEF  164 ±  4  55 ±  4  250 ±  10  NT* 
Chang  29 ±  1  12 ±  1  20 ±  1  NT 
* Chemiluminescence of NK-enriched Percoll fraction lymphocytes in response to various target cells was 
measured over a  10-rain  period, and the area under the curve was integrated. The data for each target 
are expressed as the mean percent +  S  E of total cpm stimulated by K562 cells over the same time period 
in triplicate samples. The actual control value was 3.2 X  105 total counts over 10 rain. Each experiment 
was done at least three times and some were done five times. 
:~ Conjugates  were  formed  with  an  excess  of target  cells  using the  NK-enriched  Percoll  fractionated 
lymphocytes. Values represent the mean +  SE in triplicate determinations. 
§ Monocyte-depleted peripheral blood lymphocytes were tested in a  SlCr release assay for  18 h  against 
L5178Y, P815, and YAC and were tested for 4 h  for all the other targets. LU were calculated at 20% 
lysis. LU values for K562 target cells run in parallel assays for 4 h (900 LU/107) or 18 h (1,100 LU/107) 
were normalized to 100%, and the other values were compared with it. Values represent the mean +  SE 
of triplicate samples. 
II Monocytes (>95% esterase and Mo2  +) isolated by plastic adherence were tested in an 18-h SlCr release 
assay against each target. Values for L5178Y target cells  (330 LU/107) run in parallel were normalized 
to  100% and  the  others compared  with  it.  Values  represent  the  mean  +  SE  of triplicate samples. 
Chemiluminescence vs. conjugates: r =  0.93; P <  0.01. Chemiluminescence vs. NK cytolysis:  r =  0.98;  P 
<  0.001. NK cytolysis  vs. conjugates: r =  0.98;  P <  0.1301. 
* Not tested. 
in an  18-h assay (1-5% of K562 control), and they were likewise deficient in inducing 
chemiluminescence  (15-20%  of K562  control)  (Table  II,  Fig.  3,  panel  b).  Human 
embryonic  fibroblasts (HEF)  were  more sensitive than  K562 to NK-mediated  killing 
(250% of K562 control), and they also induced a  higher amount  of chemiluminescence 
(164%  as compared  with  K562  control)  (Fig.  3,  panel  c).  Chang,  on the other  hand, 
is  intermediate  in  sensitivity  to  NK-mediated  cytolysis  (20%  of K562  control)  and 
induced  the generation  of an intermediate  (29%) chemiluminescence  response  (Fig. 3, 
panel  d). 
These  data  indicate that  the amount  of chemiluminescence  generated  in response 
to the NK  target-effector interaction  is directly related to the sensitivity of the target 
cell to NK-mediated  binding  and lysis. It was then relevant to ask whether  the degree 
of NK  activation  for cytolysis also influenced the level of chemiluminescence. 
Interferon is known  to have a  profound  boosting effect on human  NK  cell cytolytic 
activity (19). As shown in Table  III, interferon pretreatment  of NK-enriched  lympho- 
cytes significantly increased the level of cytotoxicity against  MeWo  and  K562  target 
cells by  150% and  50%, respectively. The  amount  of chemiluminescence  generated  by 
interferon  pretreated  cells was  increased  in  parallel  by  50%  for  MeWo  (Fig.  4)  and 
20%  for  K562  targets  (Table  III).  These  data  show  that  agents  such  as  interferon, STEPHEN  L.  HELFAND, JEROME  WERKMEISTER,  AND JOHN  C.  RODER 
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Fro.  3.  Induction of chemiluminescence by cell  lines of varying susceptibility to  NK cytolysis. 
Mooocyte-depleted peripheral blood lymphocytes were separated on Percoll density gradients, and 
the fraction highest in NK-mediated cytotoxicity was selected for further study. 5  ×  105 of these 
lymphocytes were mixed with  10  v target cells at time 0  in the presence of luminol, and cpm were 
recorded every 5 s on an LKB liquid scintillation counter in the out-of-coincidence mode. Values 
represent cpm above background. The area under each curve varied <4% in repeat samples. The 
experiments were repeated 5, 4, 3, and 3 times for panels A, B, C, and D, respectively, with similar 
results. Panel A shows uninduced parental K562 cells (×), induced K562-clone A4 cells (D), induced 
K562-clone G8 ceils (O), and induced K562-clone B cells (A). Panel B shows K562 cells (x), YAC 
cells (O), L5178Y cells (A), or P815 cells (Fl).  Panel C  shows K562 cells (X) or human embryonic 
fibroblast cells (0).  HEF peak at  180  ×  l0  g cpm at  10 min. Panel D  shows K562 cells (×)  or  l0  T 
Chang cells (O). 
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which boost NK activity, also boost the generation of chemiluminescence. We then 
asked whether other effector cell types could generate chemiluminescence. 
Chemiluminescence and Cytotoxicity by Monocytes.  Macrophages and  granulocytes are 
known to generate chemiluminescence and, therefore, we felt it was necessary to prove 
that  contamination with  these cell types was not responsible for the chemilumines- 
cence we attribute  to NK cells.  Preparation of the effector cells  for our chemilumi- 
nescence assay included Ficoll separation, iron and magnet treatment, plastic adher- 
ence depletion, and Percoll density gradient fractionation. 
Less  than  0.1%  of the  cells  recovered  were  granulocytes,  as judged  by  Giemsa 500  CHEMILUMINESCENCE RESPONSE OF HUMAN NATURAL KILLER CELLS 
TABLE  III 
Chemiluminescence in Interferon-activated NK Cells 
Chemilumi-  NK Cytoly- 
nescence~  ski[ 
Target  Treatment*  P value§  P value 
Percent  Percent 
control  control LU 
MeWo  No interferon  100  100 
MeWo  With interferon  150  <0.01  250  <0.001 
K562  No interferon  100  100 
K562  With interferon  120  <0.02  150  <0.01 
* Lymphocytes were treated with 200 U of beta (fibroblastic) interferon for 1 h and washed 
or left untreated. 
Chemiluminescence was measured over a  10-min  period, and the area under the curve was 
integrated.  The percent chemiluminescence is derived  by total cpm treated  lymphocytes 
per total cpm untreated lymphocytes X  100. Variations in repeat samples were <3%. The 
actual values for untreated MeWo and K562 were  1.75 x  105 and 9.05  X  105 total cpm 
over 10 min. 
§ Monocyte-depleted peripheral blood lymphocytes were interferon-activated or untreated 
and  were tested in a  4-  or  18-h SlCr  release assay against K562  and  MeWo target cells, 
respectively. LU/107 values for untreated lymphocytes were  1,300 for K562  and  110  for 
MeWo. These values were normalized to  100% for comparison with treated lymphocytes 
run in parallel. 
[[ P values were determined by a Student's t test for data from three repeat experiments per 
group. 
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Fro.  4.  Induction of chemiluminescence in interferon-activated lymphocytes. Monocyte-depleted 
peripheral blood lymphocytes were separated on Percoll  density gradients, and the fraction highest 
in  NK-mediated cytotoxicity  was selected  for further study.  5  ×  10  5 of these lymphocytes were 
5 ×  10  interferon-  treated for 1 h (at 25-37°C) with 200 U of  B interferon (fibroblastic) and washed,  s 
treated (X) or untreated (O) lymphocytes were mixed with 107 MeWo cells at time 0 in the presence 
of lumlnol, and cpm were recorded every 5 s on an LKB liquid scintillation counter in the out-of- 
coincidence  mode.  Values represent cpm above background. The area  under each  curve varied 
<3% in repeat samples. This experiment was repeated three times with similar results. STEPHEN L. HELFAND, JEROME WERKMEISTER,  AND JOHN C. RODER 
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FIG. 5.  The chemiluminescent response of granulocytes and  monocytes to  NK-sensitive and 
resistant targets. Monocytes (>95% esterase-positive,  peroxidase-positive,  and Mo2  +) were isolated 
by plastic adherence. Monocyte-depleted peripheral blood lymphocytes were separated on Percoll 
density gradients, and the fraction highest in NK-mediated cytotoxicity was selected for further 
study. Granulocytes (>99% polymorphonuclear and 99.5% positive  for monoclonal  antibody against 
PMN) were isolated from leukocyte pellets after depletion of mononuclear ceils on Ficoll-Hypaque. 
5 ×  105 NK-enriched lymphocytes (X), 105 monocytes (O), or 105 granulocytes (A) were mixed with 
107 K562 cells at time 0 in the presence  of luminol. 10  s monocytes  were also mixed with 107 L5178Y 
cells (0). Counts per minutes were recorded every 5 s on an LKB liquid scintillation counter in the 
out-of-coincidence  mode. Values represent cpm above background. 10  s monocytes or granulocytes 
alone gave no response above background. The area under each curve varied <3% in triplicate 
samples, and differences between curves X and O, or •  and A, were significant at the P < 0.001 
level. This experiment was repeated three times with similar results. 
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staining and  morphology  or  by  immunofluorescent staining with  a  monoclonal 
antibody specific for human granulocytes. 60% of the Percoll-enriched cells expressed 
the  NK-specific marker HNK-1  (16),  and 40%  expressed T3, a  T  cell marker  (20). 
Staining with Mo2, a  specific monoclonal antibody against human monocytes (14), 
or with nonspecific esterase and peroxidase revealed <  1% Mo2  + cells in non-Percoll 
fractionated cells and <0.1%  Mo2  ÷  cells out  of  1,000  cells counted in the  Percoll 
fraction used for chemiluminescence. When the plastic adherence step was left out, 
the  Percoll fraction used for chemiluminescence was  found to  have  10-25%  Mo2  ÷ 
cells. In each of these cases where the Percoll fraction had 0.1, 10, or 25% Mo2  ÷ cells, 
there was  no difference in the  generation of chemiluminescence (data  not shown). 
Conversely,  monocyte-enriched adherent  cells  (90-95%  acid  esterase-positive  and 
Mo2  ÷) were assayed alone in the chemiluminescence  assay at  105 cells per vial, which 
is equivalent to 20% macrophage contamination in our standard Percoll fraction of 5 
×  l0  s ceils per vial. As shown in Fig. 5,  10  s monocytes per vial gave only a  minimum 
response to the K562 stimulus that was 7% of that in the NK-enriched Percoll fraction 
stimulated with K562 (P <  0.001).  10  s granulocytes gave no response• As a  positive 
control, 105 granulocytes generated a  peak chemiluminescence response of 120 X  103 
cpm at 40 rain in response to 3 X  l0  s opsonized Escherichia coli per ml.  104 monocytes 
or  104 granulocytes also gave no response alone or when added to Percoll fraction 2 
cells (data not shown)• 
Finally, some  targets,  such  as  L5178Y,  showed  poor  killing by NK cells  (1%  of 502  CHEMILUMINESCENCE RESPONSE OF HUMAN NATURAL KILLER CELLS 
K562  control)  and  a  corresponding inability to induce chemiluminescence  (15% of 
K562 control), as shown above in Table II. In contrast, L5178Y was the most sensitive 
monocyte target (Table II) and also induced four- to fivefold more chemiluminescence 
than K562 in monocytes (P <  0.001)  (Fig.  5). YAC  followed this same pattern, and 
repeat experiments, using monocytes isolated on Percoll gradients (21) rather than by 
adherence, gave similar results (data not shown). 
Discussion 
These  results  show  that  target-effector contact  induces  the  NK cell  to  trigger  a 
chemiluminescence response.  The target structures  recognized by the  NK cell may 
play  a  role  in  this  rapid  activation  because  the  amount  of  chemiluminescence 
produced is directly proportional to the ability of a  given target cell line to bind to 
the NK cell and be lysed. 
In the present study, we examined a  panel of nine different  target cell lines and 
found a  striking correlation  (r >  0.93)  between target-effector conjugate formation, 
induction  of chemiluminescence  in  NK  cells,  and  susceptibility  to  NK-mediated 
cytolysis.  The  highly  sensitive  human  tumor cell  line  K562  was  shown  to  lose  its 
sensitivity to NK-mediated binding and cytolysis when induced to differentiate with 
butyrate  (Table  II).  This  change  in  NK  sensitivity  was  highly  selective  because 
sensitivity to antibody-dependent cell-mediated cytotoxicity and monocyte-mediated 
cytolysis was not altered in differentiated clones (13).  K562 clones A4, B, and G8 also 
triggered only 30-48% of the chemiluminescence induced  by the K562 parent cells. 
This correlation between  ability to form target-effector conjugates, susceptibility to 
NK-mediated lysis, and the amount of chemiluminescence generated held for all the 
other targets as well. The relatively NK-insensitive targets YAC, P815,  and L5178Y 
formed few target-effector conjugates and induced only a  low level of chemilumines- 
cence.  Highly NK-sensitive cell targets  (HEF)  were able to induce a  corresponding 
high  amount  of chemiluminescence,  and  cell  lines  (Chang)  of  intermediate  NK 
sensitivity induced an intermediate amount of chemiluminescence. 
Glutaraldehyde fixation of K562 cells was shown to preserve the target structure to 
varying degrees,  as  determined  by the  ability of these  fixed cells  to compete with 
unfixed K562 cells in a cold target inhibition assay or bydirect visualization of target- 
effector conjugates. Here too, we found a strong correlation (r >  0.95) between ability 
to compete for the NK receptor and ability to trigger chemiluminescence  (Table I, 
Fig.  2).  These results are compatible with  those of Bubbers and  Henney  (22),  who 
showed that tumor cell targets treated with 0.3% glutaraldehyde lost their ability to 
specifically  bind  alloimmune  killer  T  cells,  whereas  targets  treated  with  0.15% 
glutaraldehyde  retained this ability. The data presented  here suggests that  it is the 
target  structure  binding  to  the  NK  receptor  itself  that  may  be  the  trigger  for 
chemiluminescence. Intact target cells were not necessary because cell-free membrane 
vesicles made from  NK-sensitive but  not  NK-insensitive targets  also  induced  high 
levels  of  chemiluminescence.  The  observation  that  glutaraldehyde-fixed  effectors 
bound to intact target cells but did not generate chemiluminescence suggests that  (a) 
the effector is  responding  to the  target  and  not  the converse, and  (b)  binding  is  a 
necessary but not sufficient stimulus for chemiluminescence. 
The state of NK activation was also found to influence the generation of chemilu- 
minescence  upon  target-effector  interaction.  As  shown  in  Fig.  4  and  Table  III, STEPHEN  L.  HELFAND, JEROME WERKMEISTER,  AND JOHN C. RODER  503 
interferon pretreatment of NK-enriched lymphocytes caused a concomitant increase 
in chemiluminescence induced by MeWo and  K562 and  a  subsequent  increase in 
NK-mediated cytolysis of both targets. The degree of augmentation of both chemi- 
luminesence and cytolysis in interferon-boosted vs. -nonboosted effectors was greater 
with MeWo target cells compared with K562.  Preliminary results have shown that 
oxygen radical  scavengers block the  interferon boosting of NK-mediated  cytolysis 
(unpublished observation). 
The responder cell that generates chemiluminescence after target-effector interac- 
tion  is  most  likely an  NK cell for a  variety of reasons.  First,  the  Percoll-enriched 
fraction  contained  60%  of cells  bearing  the  NK-specific  differentiation  antigen 
HNK-1  described  by  Abo  and  Balch  (16).  The  remaining  40%  of the  cells  were 
predominantly T3  + T cells (20); and few, if any, monoeytes (<0.1%) bearing the Mo2 
marker  (14)  or  characteristic  cytochemical  markers  were  detected.  We  have  also 
shown (23) that removal of HNK-1 + cells with monoclonal anti-HNK-1 and comple- 
ment  abolishes the chemiluminescence response, and  Percoll fractions consisting of 
nearly  100% T  cells have no chemiluminescence response. It should be emphasized 
that  monocytes do  not  express  HNK-1  (16),  and,  conversely, the  Mo2  marker  is 
apparently specific for the entire human monocyte population (14) and does not react 
with NK cells (unpublished observation). Furthermore, purified populations of mon- 
oeytes or granulocytes generated very little chemiluminescence against  K562 at cell 
concentrations derived on the assumption of a  20% monocyte contamination of our 
NK-enriched  populations  (Fig.  5).  Deliberate  contamination  of our  NK-enriched 
Percoll fraction did not alter the chemiluminescence induced by K562. Therefore, a 
monocyte or granulocyte contamination of our NK-enriched effectors cannot account 
for the observed chemiluminescence. 
At high cell numbers, monocytes were capable of generating a chemiluminescence 
response to those tumor cell lines that were sensitive to monocyte-mediated cytolysis 
but resistant to NK-mediated lysis (Fig. 5). Nonphagocytie killing of tumor cells by 
murine macrophages has been shown to involve H202 production (11). These results 
suggest that NK recognition and binding to target determinants triggers the NK cell 
to  induce chemiluminescence. The underlying basis  of this  chemiluminescence re- 
sponse may involve 02- production in part because NK-target interaction also reduces 
extracellular cytochrome c  at  a  rate  of 200  pmol/min  per  l0  s  cells9  Preliminary 
results show that SOD (<_100 #g/ml, 280 U/ml) but not catalase (100 #g/ml,  1,180 
U/ml) or denatured SOD block most (80%) of the NK-mediated chemiluminescence, 
cytochrome  c  reduction,  and  cytolysis  with  no  effect  on  target-effector binding 
(unpublished data). Although 02- and possibly other highly reactive molecules might 
be involved in the chemiluminescence response shown here, further work is necessary 
to determine whether they activate other events in the cytolytic pathway or play a 
direct role in delivering the lethal hit. 
Summary 
The binding of tumor cells or fetal fibroblasts to human natural killer (NK) cells 
led to a  rapid chemiluminescence response within seconds of target-effector interac- 
tion. The degree of chemiluminescence was dependent on the concentration of NK- 
2 Roder, J. C., S. L. Helfand, J. A. Werkmeister, R. MeGarry, T. J. Beaumont, and A. Duwe. Oxygen 
intermediates are triggered early in the cytolytie pathway of human NK cells. Nature (Lord.). In press. 504  CHEMILUMINESCENCE RESPONSE OF HUMAN NATURAL KILLER CELLS 
enriched lymphocytes or target cells, and plasma membrane vesicles from K562 also 
induced  a  chemiluminescence  response.  Mild  glutaraldehyde  treatment  of effector 
cells abrogated their ability to generate chemiluminescence, whereas K562 target cells 
treated  in  the  same  way  were  almost  fully  able  to  induce  a  chemiluminescence 
response to NK-enriched lymphocytes. These results show a directionality of response 
with  NK  as  the  responders  and  tumor  cells  as  the  stimulators.  A  survey of eight 
different  tumor cell lines and fetal fibroblast lines revealed a  striking correlation  (r 
>  0.93,  P  <  0.001)  between  the  ability  of a  given  line  to  bind  to  NK-enriched 
lymphocytes, induce chemiluminescence, and to be lysed. Three differentiated sublines 
of K562  grown in butyrate and cloned induced  little chemiluminescence compared 
with  the K562 parent,  and they were selectively resistant  to NK-mediated binding 
and  cytolysis.  In  addition,  treatment  of K562  cells  with  higher  concentrations  of 
glutaraldehyde for longer periods led to varying degrees of target antigen preservation, 
as measured in cold target competition assays and in conjugate formation. The degree 
of NK target antigen preservation correlated directly with the ability of the cells to 
induce chemiluminescence (r >  0.95). The degree of NK activation was also important 
because interferon-pretreated effectors generated more chemiluminescence upon stim- 
ulation with K562 or MeWo targets. Monocytes or granulocytes did not contribute to 
the chemiluminescence  induced  by NK-sensitive targets.  Some NK-resistant  tumor 
cell lines were sensitive to monocyte-mediated cytolysis and also induced chemilumi- 
nescence in monocytes but not NK cells. These results show that the target structures 
recognized by the NK cell may play a  role in NK activation because the degree of 
chemiluminescence was directly proportional to the ability of a given target cell line 
to bind to the NK cell and to be lysed. 
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